Yang Wen

Yang Wen has extensive experience in the pharmaceutical industry, particularly at Roche from April 2013 to August 2022, serving as a Senior Regulatory Content Strategist and Regulatory Documentation Scientist, with responsibilities including clinical study reports and regulatory documentation leadership. In a previous role as a Scientist at Roche, Yang Wen developed high-throughput screening strategies and received multiple awards for assay development. Prior experience includes work as a Research Associate III at Regeneron Pharmaceuticals, focusing on assay development and validation for pre-clinical studies. Yang Wen holds a Master of Science degree in Developmental Neuroscience from Rutgers University.